Nutex Health, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2023 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Nutex Health, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2023 to Q1 2024.
- Nutex Health, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$95.4K, a 89.5% increase year-over-year.
- Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$5.71M, a 214% decline from 2022.
- Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $5M.
- Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$985K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)